Ultrasound stiffness test for fatty liver disease
Part of Digestive system clinical trials.
This study uses a special ultrasound technique, called shear wave elastography, to measure liver stiffness during an endoscopic ultrasound (EUS) procedure. It aims to see how well this new method detects liver scarring (fibrosis) in people with fatty liver disease, compared to standard tests like FibroScan and liver biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You are already scheduled for an endoscopic ultrasound (EUS) and a liver biopsy (within 3 months of each other).
- You have had or will have a FibroScan test within 3 months of the EUS.
- Your body mass index (BMI) is 28 or higher.
- You have a clinical suspicion of fatty liver disease (MASLD or MASH) with or without liver scarring.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an ultrasound probe during a routine endoscopy to measure liver stiffness, which can help detect liver scarring (fibrosis) in people with fatty liver disease (MASLD). If you are already scheduled for an endoscopy and have no signs of advanced liver scarring, you may be able to join.
This study tests a new ultrasound device that uses sound waves to measure fat in the liver without needles or surgery. It is for people with a type of fatty liver disease called MASLD or MASH, who are already getting an MRI to check their liver.
This study explores if a new ultrasound technique can detect fatty liver disease in children. It aims to find a simpler, safer way to check liver health without needing an MRI or biopsy.
This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.
This study uses advanced ultrasound imaging and artificial intelligence to assess heart health in people with fatty liver disease (a condition where fat builds up in the liver). The goal is to better manage heart disease risk in these patients.
This trial tests a special ultrasound technique during an endoscopy to see how well it can detect changes in the liver from non-alcoholic fatty liver disease. It may help improve non-invasive assessment before or alongside a follow-up liver biopsy.
Hear when a new MASLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.